Ambiq Micro president sells 15,000 shares

Q: How many AMBQ shares did its president sell, and at what prices?

Sean Chihhsiang Chen sold 15,000 common shares on October 14, 2026, in five reported transactions: 7,539 at a weighted average of $50.1290 (prices ranged from $50.00 to $50.98); 1,261 at $51.5306 ($51.00 to $51.90); 2,000 at $52.4682 ($52.02 to $53.01); 4,000 at $53.4363 ($53.04 to $53.91); and 200 at $54.2700.

Q: How many AMBQ options did Sean Chihhsiang Chen exercise, and at what price?

Chen exercised options for 15,000 common shares at $8.12 per share on October 14, 2026. The transactions occurred under a Rule 10b5-1 plan adopted June 5, 2026.

One-quarter of the option shares vested on February 21, 2020, followed by equal monthly installments subject to continued service.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Ambiq Micro, Inc. President and COO Sean Chihhsiang Chen exercised options for 15,000 common shares at $8.12 per share on October 14, 2026, and acquired 15,000 common shares. That day, he sold 15,000 common shares in five reported transactions: 7,539 at a weighted average of $50.1290; 1,261 at $51.5306; 2,000 at $52.4682; 4,000 at $53.4363; and 200 at $54.2700 per share. The transactions occurred under a Rule 10b5-1 plan adopted June 5, 2026.

Insider Trade Summary 10b5-1

Exercise and Sale: 15,000 shares ($651K approx. pre-tax spread)

Exercise and Sale 7 txns

Insider Chen Sean Chihhsiang

Role President and COO

Sold 15,000 shs ($772K)

Approx. gross sale proceeds $772K

Approx. exercise cost $122K

Approx. pre-tax spread $651K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy) ^{F1, F6}	15,000	$0.00	$0.00
Exercise	Common Stock ^F1	15,000	$8.12	$122K
Sale	Common Stock ^{F1, F2}	7,539	$50.129	$378K
Sale	Common Stock ^{F1, F3}	1,261	$51.5306	$65K
Sale	Common Stock ^{F1, F4}	2,000	$52.4682	$105K
Sale	Common Stock ^{F1, F5}	4,000	$53.4363	$214K
Sale	Common Stock ^F1	200	$54.27	$11K

Holdings After Transaction: Stock Option (Right to Buy) — 119,423 contracts (Direct); Common Stock — 106,268 shares (Direct)

Footnotes (6)

F1. The transactions reported in this Form 4 occurred under a Rule 10b5-1 plan adopted by the Reporting Person on June 5, 2026
F2. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.98 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $51.00 to $51.90 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $52.02 to $53.01 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $53.04 to $53.91 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6. 1/4 of the shares subject to the option vested on February 21, 2020, and 1/48 of the shares subject to the option vested in equal monthly installments thereafter, subject to the Reporting Person's continued service.

Key Figures

Options exercised: 15,000 shares Exercise price: $8.12 per share Shares sold: 7,539 shares at $50.1290 per share +5 more

8 metrics

Options exercised 15,000 shares October 14, 2026

Exercise price $8.12 per share Options exercised October 14, 2026

Shares sold 7,539 shares at $50.1290 per share Weighted average sale price; transaction prices ranged from $50.00 to $50.98

Shares sold 1,261 shares at $51.5306 per share Weighted average sale price; transaction prices ranged from $51.00 to $51.90

Shares sold 2,000 shares at $52.4682 per share Weighted average sale price; transaction prices ranged from $52.02 to $53.01

Shares sold 4,000 shares at $53.4363 per share Weighted average sale price; transaction prices ranged from $53.04 to $53.91

Shares sold 200 shares at $54.2700 per share October 14, 2026

Option shares following transaction 119,423 shares Reported position following the October 14, 2026 option transaction

Key Terms

Rule 10b5-1 plan, weighted average sale price, Stock Option (Right to Buy)

3 terms

Rule 10b5-1 plan regulatory

"transactions ... occurred under a Rule 10b5-1 plan"

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

weighted average sale price financial

"reported price ... is a weighted average sale price"

Stock Option (Right to Buy) financial

"Stock Option (Right to Buy)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many AMBQ shares did its president sell, and at what prices?

Sean Chihhsiang Chen sold 15,000 common shares on October 14, 2026, in five reported transactions: 7,539 at a weighted average of $50.1290 (prices ranged from $50.00 to $50.98); 1,261 at $51.5306 ($51.00 to $51.90); 2,000 at $52.4682 ($52.02 to $53.01); 4,000 at $53.4363 ($53.04 to $53.91); and 200 at $54.2700.

How many AMBQ options did Sean Chihhsiang Chen exercise, and at what price?

Chen exercised options for 15,000 common shares at $8.12 per share on October 14, 2026. The transactions occurred under a Rule 10b5-1 plan adopted June 5, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 10/16/2026 - 04:52 PM EDT Accepted by SEC EDGAR 10/16/2026 - 04:51 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chen Sean Chihhsiang

(Last)

(First)

(Middle)

C/O AMBIQ MICRO, INC.

6500 RIVER PLACE BLVD BUILDING 7 STE 200

(Street)

AUSTIN

TEXAS

78730

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Ambiq Micro, Inc. [ AMBQ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President and COO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	10/14/2026		M⁽¹⁾		15,000	A	$8.12	121,268	D
Common Stock	10/14/2026		S⁽¹⁾		7,539	D	$50.129⁽²⁾	113,729	D
Common Stock	10/14/2026		S⁽¹⁾		1,261	D	$51.5306⁽³⁾	112,468	D
Common Stock	10/14/2026		S⁽¹⁾		2,000	D	$52.4682⁽⁴⁾	110,468	D
Common Stock	10/14/2026		S⁽¹⁾		4,000	D	$53.4363⁽⁵⁾	106,468	D
Common Stock	10/14/2026		S⁽¹⁾		200	D	$54.27	106,268	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$8.12	10/14/2026		M⁽¹⁾			15,000	⁽⁶⁾	02/20/2029	Common Stock	15,000	$0	119,423	D

Explanation of Responses:

1. The transactions reported in this Form 4 occurred under a Rule 10b5-1 plan adopted by the Reporting Person on June 5, 2026

2. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.98 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $51.00 to $51.90 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

4. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $52.02 to $53.01 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

5. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $53.04 to $53.91 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

6. 1/4 of the shares subject to the option vested on February 21, 2020, and 1/48 of the shares subject to the option vested in equal monthly installments thereafter, subject to the Reporting Person's continued service.

	/s/ Jeffrey Winzeler, Attorney-in-Fact	10/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR